Maternal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae in term versus preterm pregnancies

Int J Gynaecol Obstet. 2023 May;161(2):447-454. doi: 10.1002/ijgo.14555. Epub 2022 Nov 22.

Abstract

Objectives: To examine the prevalence and risk factors of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) colonization among women who delivered preterm and at term.

Methods: A prospective observational study of maternal ESBL-E rectovaginal colonization in threatened preterm labor and low-risk term pregnancies was conducted between March 2017 and August 2021 at the Galilee Medical Center, Israel. Obstetric and neonatal complications were compared between colonized and non-colonized mothers and neonates.

Results: ESBL-E colonization was similar in the preterm (n = 202) and term (n = 172) groups: 14.4% and 16.9%, respectively (P = 0.567). The maternal-neonatal transmission rate was higher in the preterm than the term group but the difference was not statistically significant: 42.1% and 22.2%, respectively (P = 0.42). Prematurity was a risk factor of neonatal ESBL-E colonization (odds ratio 1.33, 95% confidence interval 1.01-1.75, P = 0.041). ESBL-E-colonized preterm infants were delivered at an earlier gestational age and were more likely to have complications. Maternal ESBL-E colonization and transmission were more prevalent in pregnancies complicated by threatened preterm labor or premature rupture of membranes than in term pregnancies.

Conclusions: These findings emphasize the need for further research on the cost-effectiveness of screening for maternal ESBL-E colonization in preterm labor, to prevent neonatal infectious complications.

Clinicaltrials: gov identifier NCT03251885.

Keywords: extended-spectrum β-lactamase-producing Enterobacteriaceae; maternal colonization; neonatal infections; screening; transmission rate.

Publication types

  • Observational Study

MeSH terms

  • Enterobacteriaceae
  • Enterobacteriaceae Infections* / diagnosis
  • Enterobacteriaceae Infections* / epidemiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Obstetric Labor, Premature* / epidemiology
  • Pregnancy
  • Risk Factors
  • beta-Lactamases

Substances

  • beta-Lactamases

Associated data

  • ClinicalTrials.gov/NCT03251885